Inventor
SHIRAI FUMIYUKI
JP15 patents
⚠️ This page may combine multiple inventors who share the name “SHIRAI FUMIYUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
6 patentsUS4935507AJun 19, 1990
Crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid (syn isomer)
FUJISAWA PHARMACEUTICAL CO89 citations95
US5286721AFeb 15, 1994
1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
FUJISAWA PHARMACEUTICAL CO20 citations91
US5102877AApr 7, 1992
1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
FUJISAWA PHARMACEUTICAL CO36 citations91
US5241064AAug 31, 1993
Enzymatic process for preparing optically active 3-substituted azetidinones
FUJISAWA PHARMACEUTICAL CO6 citations61
US5075437ADec 24, 1991
3,4-disubstituted-2-azetidinone derivatives and processes for preparation using tin enolates
FUJISAWA PHARMACEUTICAL CO5 citations61
US6468995B1Oct 22, 2002
Cephem compounds
FUJISAWA PHARMACEUTICAL CO3 citations58
ASTELLAS PHARMA INC
6 patentsUS7465731B2Dec 16, 2008
HDAC inhibitor
ASTELLAS PHARMA INC18 citations91
US7557127B2Jul 7, 2009
HDAC inhibitor
ASTELLAS PHARMA INC8 citations83
US7183306B2Feb 27, 2007
Pyrazole derivatives
ASTELLAS PHARMA INC15 citations83
US9585889B2Mar 7, 2017
Nitrogen-containing bicyclic aromatic heterocyclic compound
ASTELLAS PHARMA INC0 citations47
US9328118B2May 3, 2016
Nitrogen-containing bicyclic aromatic heterocyclic compound
ASTELLAS PHARMA INC0 citations47
US7750155B2Jul 6, 2010
Pyrazinyl hydroxyacrylamide compounds having an inhibitory effect on the activity of histone deacetylase
ASTELLAS PHARMA INC0 citations35
RIKEN
3 patentsUS11414429B2Aug 16, 2022
Compound or pharmaceutically acceptable salt thereof
RIKEN2 citations56
US11566017B2Jan 31, 2023
Dihydroquinazolinone compound or pharmacologically acceptable salt, and cell growth inhibitor
RIKEN0 citations45
US12544354B2Feb 10, 2026
Mitochondrial permeability transition pore (mPTP)-opening inhibitor, novel compound exhibiting mPTP-opening inhibitory activity, and use therefor
RIKEN0 citations35